机译:Staurosporlne衍生的抑制剂拓宽了模拟敏感激酶技术的范围
Howard Hughes Medical Institute and Department of Cellular & Molecular Pharmacology, University of California, San Francisco,California 94143, United States,Graduate Program in Chemistry and Chemical Biology, University of California, San Francisco, California 94158, United States;
Howard Hughes Medical Institute and Department of Cellular & Molecular Pharmacology, University of California, San Francisco,California 94143, United States,Graduate Program in Chemistry and Chemical Biology, University of California, San Francisco, California 94158, United States;
Howard Hughes Medical Institute and Department of Cellular & Molecular Pharmacology, University of California, San Francisco,California 94143, United States;
Howard Hughes Medical Institute and Department of Cellular & Molecular Pharmacology, University of California, San Francisco,California 94143, United States;
Department of Physiology, University of California, San Francisco, California 94158, United States;
Howard Hughes Medical Institute and Department of Cellular & Molecular Pharmacology, University of California, San Francisco,California 94143, United States,Department of Chemistry, University of California, Berkeley, California 94720, United States;
机译:结构导向的抑制剂设计扩展了类似敏感性激酶技术的范围
机译:加速技术:混合技术正在普及/扩大其涵盖性能的范围,并推动行业合作
机译:eomes通过抑制低亲和力细胞的细胞凋亡来扩大CD8 T细胞记忆的范围
机译:技术验收的条件扩大了ICT拨款的决定因素的范围
机译:新的抑制剂支架的设计和开发扩大了类似物敏感激酶技术的范围。
机译:星形孢菌素衍生的抑制剂扩大了类似敏感性激酶技术的范围
机译:Staurosporine衍生的抑制剂拓宽了模拟敏感激酶技术的范围
机译:针对癌症治疗的选定药物遗传学测试的系统评价:CYp2D6用于乳腺癌中的他莫昔芬,KRas用于结肠直肠癌中的抗EGFR抗体,以及BCR-aBL1用于慢性髓性白血病中的酪氨酸激酶抑制剂。技术评估报告